Charles Schwab Corporation Common Stock vs Teladoc Health Inc — how do they compare? Charles Schwab Corporation Common Stock trades at $96.59 (market cap $167.52B), while Teladoc Health Inc trades at $5.6 (market cap $1.01B). The key difference: Charles Schwab Corporation Common Stock is far larger — about 165.9× Teladoc Health Inc's market cap, and Charles Schwab Corporation Common Stock pays a 1.32% dividend while Teladoc Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Charles Schwab Corporation Common Stock for 85 Days and Teladoc Health Inc for 39 Days on average.
| SCHW | TDOC | |
|---|---|---|
Market Cap | $167.52B | $1.01B |
Volume | 6,554,126 | 4,668,477 |
Sector | Financials | Health |
52-Week High | $113.65 | $9.72 |
52-Week Low | $85.35 | $4.47 |
Typical Hold Time | 85 Days | 39 Days |
Enterprise Value | $153.97B | $1.27B |
Dividend Yield | 1.32% | — |
Signals from Pluang's Aura AI — not financial advice
Charles Schwab (SCHW) trades at $95.58, down 1.26% today, amid bearish technical signals despite strong fundamentals. The stock shows consistent earnings beats with Q2 2026 EPS of $1.62 exceeding expectations of $1.56, while revenue grew to $23.92B in 2025. Analyst consensus remains bullish with a $119.92 price target, though technical indicators show selling pressure with RSI at oversold levels and bearish moving average alignment.
SCHW presents a compelling value opportunity with attractive valuation metrics (P/E 17.64) and robust profitability (ROE 22.45%), but faces near-term technical headwinds and market volatility risks. The company's expansion into AI integration and Texas Stock Exchange listing provides growth catalysts, though investors should monitor interest rate sensitivity and competitive pressures in the brokerage sector.
Teladoc Health (TDOC) trades at $5.56, down 3.64% on the day, reflecting persistent bearish technical signals and negative earnings. The stock shows weak profitability with a net income margin of -7.13% and negative ROE, though valuation ratios like P/S of 0.4 and EV/EBITDA of 5.89 appear low. Recent news includes a CFO transition and ongoing investor investigations, adding to uncertainty.
The outlook remains challenging due to consecutive net losses and competitive pressures, but the consensus price target of $8.83 suggests potential upside if operational improvements materialize. Key risks include sustained unprofitability, high debt levels, and weak sentiment, requiring careful monitoring of cost management and revenue stabilization efforts.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Charles Schwab operates in brokerage, banking, and asset-management businesses. The company runs a large network of brick-and-mortar brokerage branch offices, a well-established online investing website, and has mobile trading capabilities. It also operates a bank and a proprietary asset management business and offers services to independent investment advisors. The company is among the largest firms in the investment business, with over $8 trillion of client assets at the end of 2021. Nearly all of its revenue is from the United States.
Read more on SCHW →Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →